Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DZM0J8
|
|||
Drug Name |
PSB202
|
|||
Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Phase 1 | [1] | |
Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C82-C85; ICD-9: 200, 202] | Phase 1 | [1] | ||
Company |
Sound Biologics Bothell, WA
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT05003141) A Phase 1a/1b Study of PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.